DCAF16-mediated SMARCA2 selective targeted glues

N/A

Report date: 2026/05/06 20:02:28
NME

Base Information

Drug NameDCAF16-mediated SMARCA2 selective targeted glues
Drug Alias NameN/A
ClassificationSmall molecules > Molecular Glue
Mechanisms of ActionProbable global transcription activator SNF2L2 degradersDDB1- and CUL4-associated factor 16 modulators
TargetsProbable global transcription activator SNF2L2DDB1- and CUL4-associated factor 16
Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAmphista Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAmphista Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell Lung
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A